Cytosorbents Corporation 8-K Filing: Key Insights from January 6, 2025 Report

Here are the key insights and information extracted from the provided section of the financial report for Cytosorbents Corporation:

1. Filing Type: The document is an 8-K filing, which typically reports unscheduled material events or corporate changes that are important to shareholders.
2. Company Information:

• Name: Cytosorbents Corporation
• CIK Number: 0001175151
• State of Incorporation: Delaware (DE)
• Company's SEC File Number: 001-36792
• EIN: 98-0373793
• Address: 305 College Road East, Princeton, NJ 08540
• Phone: 732-329-8885
• Stock Exchange: NASDAQ
• Ticker Symbol: CTSO
• Par Value of Common Stock: $0.001

3. Reporting Period: The report covers a specific date, January 6, 2025.
4. Units of Measure:

• The financial measures are reported in US Dollars (USD) and shares.
• There is a reference to USD per share in the context of share pricing or value.

5. Context Information:

• The report includes a schema reference indicating its compliance with XBRL standards for financial reporting.

6. Key Dates:

• As of Date: The financial data pertains to January 6, 2025.

This information provides a foundational understanding of Cytosorbents Corporation's financial reporting for the date specified and outlines the basic corporate identifiers and context for the filing. The 8-K document should be examined further for specific events or disclosures that occurred on or around this date.